LDH >2x ULN OR severe hepatic dysfunction — predictor of inferior ICI outcomes.
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-MELANOMA-ORGAN-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | pending_clinical_signoff |
| Diseases | DIS-MELANOMA |
| Sources | SRC-ESMO-MELANOMA-2024 SRC-NCCN-MELANOMA-2025 |
Red Flag Origin
| Definition | LDH >2x ULN OR severe hepatic dysfunction — predictor of inferior ICI outcomes. |
|---|---|
| Clinical direction | investigate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"comparator": ">",
"finding": "ldh_x_uln",
"threshold": 2
},
{
"finding": "child_pugh_class",
"value": "C"
}
],
"type": "lab_value"
}
Notes
LDH integral AJCC staging variable.
Used By
Indications
IND-MELANOMA-2L-KIT-IMATINIB- IND-MELANOMA-2L-KIT-IMATINIBIND-MELANOMA-2L-POST-BRAFI-IPI-NIVO- IND-MELANOMA-2L-POST-BRAFI-IPI-NIVOIND-MELANOMA-2L-POST-IO-BRAFI-MEKI- IND-MELANOMA-2L-POST-IO-BRAFI-MEKIIND-MELANOMA-2L-RELATLIMAB-NIVOLUMAB- IND-MELANOMA-2L-RELATLIMAB-NIVOLUMABIND-MELANOMA-3L-LIFILEUCEL- IND-MELANOMA-3L-LIFILEUCELIND-MELANOMA-3L-POST-LIFILEUCEL- IND-MELANOMA-3L-POST-LIFILEUCELIND-MELANOMA-ADJUVANT-PEMBRO-STAGE-III- IND-MELANOMA-ADJUVANT-PEMBRO-STAGE-IIIIND-MELANOMA-BRAF-METASTATIC-1L-DABRA-TRAME- IND-MELANOMA-BRAF-METASTATIC-1L-DABRA-TRAMEIND-MELANOMA-METASTATIC-1L-NIVO-IPI- IND-MELANOMA-METASTATIC-1L-NIVO-IPIIND-MELANOMA-METASTATIC-1L-PEMBRO-MONO- IND-MELANOMA-METASTATIC-1L-PEMBRO-MONOIND-MELANOMA-NIVO-MAINT- IND-MELANOMA-NIVO-MAINT